Cargando…

A New Era of Prostate Cancer Precision Medicine

Prostate cancer is the second most common male cancer affecting Western society. Despite substantial advances in the exploration of prostate cancer biomarkers and treatment strategies, men are over diagnosed with inert prostate cancer, while there is also a substantial mortality from the invasive di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malik, Adil, Srinivasan, Srilakshmi, Batra, Jyotsna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901987/ https://www.ncbi.nlm.nih.gov/pubmed/31850193 http://dx.doi.org/10.3389/fonc.2019.01263

Ejemplares similares

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
por: Wang, Wanyan, et al.
Publicado: (2021)

A new tumorgraft panel to accelerate precision medicine in prostate cancer
por: Béraud, Claire, et al.
Publicado: (2023)

Hepatocyte nuclear factor 1 beta: A perspective in cancer
por: Chandra, Shubhra, et al.
Publicado: (2021)

Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
por: Kamran, Sophia C., et al.
Publicado: (2021)

Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges
por: Bukłaho, Patrycja Aleksandra, et al.
Publicado: (2023)

Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer
por: Giulietti, Matteo, et al.
Publicado: (2018)

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine
por: Petitprez, Florent, et al.
Publicado: (2018)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

Molecular Characterization of Prostate Cancers in the Precision Medicine Era
por: Giunta, Emilio Francesco, et al.
Publicado: (2021)

COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
por: Seth, Sanchit, et al.
Publicado: (2020)

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
por: Katzendobler, Sophie, et al.
Publicado: (2022)

Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer
por: Flores-Morales, Amilcar, et al.
Publicado: (2017)

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
por: Davoudi, Fatemeh, et al.
Publicado: (2023)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Association Analysis of a Microsatellite Repeat in the TRIB1 Gene With Prostate Cancer Risk, Aggressiveness and Survival
por: Moya, Leire, et al.
Publicado: (2018)

The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology
por: Shui, Lin, et al.
Publicado: (2021)

Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
por: Dulaney, Caleb R., et al.
Publicado: (2016)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine
por: Lewis, Deyana D., et al.
Publicado: (2020)

SWATH-MS Based Proteomic Profiling of Prostate Cancer Cells Reveals Adaptive Molecular Mechanisms in Response to Anti-Androgen Therapy
por: Liyanage, Chamikara, et al.
Publicado: (2021)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Characterisation of cell lines derived from prostate cancer patients with localised disease
por: Moya, Leire, et al.
Publicado: (2023)

Proteomics promises a new era of precision cancer medicine
por: Wu, Chong, et al.
Publicado: (2019)

The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
por: Di Modica, Martina, et al.
Publicado: (2022)

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine
por: Hirsh, Vera
Publicado: (2015)

An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series
por: Yang, Johnny, et al.
Publicado: (2023)

Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine
por: Suh, Yoon Seok, et al.
Publicado: (2017)

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
por: Smith, Bethany, et al.
Publicado: (2017)

Genetic Association of the KLK4 Locus with Risk of Prostate Cancer
por: Lose, Felicity, et al.
Publicado: (2012)

Editorial: Clinically prediction models for gastrointestinal cancer diagnosis and prognosis in the era of precision oncology
por: Gao, Yinyan, et al.
Publicado: (2023)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Cancer Evolution in Precision Medicine Era
por: Karagiannis, Dimitris, et al.
Publicado: (2022)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

Global Inequities in Precision Medicine and Molecular Cancer Research
por: Drake, Thomas M., et al.
Publicado: (2018)

Radiomics-Guided Precision Medicine Approaches for Colorectal Cancer
por: Quraishi, Mohammed I.
Publicado: (2022)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

Artificial intelligence assists precision medicine in cancer treatment
por: Liao, Jinzhuang, et al.
Publicado: (2023)

Editorial: Precision Medicine in Oncology
por: Re, Angela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ph6bckgip5c3dsfn81uk4mhli8